These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 30081903)

  • 41. IFI6 depletion inhibits esophageal squamous cell carcinoma progression through reactive oxygen species accumulation via mitochondrial dysfunction and endoplasmic reticulum stress.
    Liu Z; Gu S; Lu T; Wu K; Li L; Dong C; Zhou Y
    J Exp Clin Cancer Res; 2020 Jul; 39(1):144. PubMed ID: 32727517
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stabilization of MOF (KAT8) by USP10 promotes esophageal squamous cell carcinoma proliferation and metastasis through epigenetic activation of ANXA2/Wnt signaling.
    Li P; Yang L; Park SY; Liu F; Li AH; Zhu Y; Sui H; Gao F; Li L; Ye L; Zou Y; Tian Z; Zhao Y; Costa M; Sun H; Zhao X
    Oncogene; 2024 Mar; 43(12):899-917. PubMed ID: 38317006
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Downregulation of AAA-domain-containing protein 2 restrains cancer stem cell properties in esophageal squamous cell carcinoma via blockade of the Hedgehog signaling pathway.
    Li N; Yu Y; Wang B
    Am J Physiol Cell Physiol; 2020 Jul; 319(1):C93-C104. PubMed ID: 31747529
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SREBP2 is upregulated in esophageal squamous cell carcinoma and co‑operates with c‑Myc to regulate HMGCR expression.
    Zhong C; Fan L; Li Z; Yao F; Zhao H
    Mol Med Rep; 2019 Oct; 20(4):3003-3010. PubMed ID: 31432128
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines.
    Jiang YY; Jiang Y; Li CQ; Zhang Y; Dakle P; Kaur H; Deng JW; Lin RY; Han L; Xie JJ; Yan Y; Doan N; Zheng Y; Mayakonda A; Hazawa M; Xu L; Li Y; Aswad L; Jeitany M; Kanojia D; Guan XY; Said JW; Yang W; Fullwood MJ; Lin DC; Koeffler HP
    Gastroenterology; 2020 Oct; 159(4):1311-1327.e19. PubMed ID: 32619460
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma.
    Guo W; Liu S; Dong Z; Guo Y; Ding C; Shen S; Liang J; Shan B
    Clin Exp Metastasis; 2018 Feb; 35(1-2):53-68. PubMed ID: 29524086
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endoplasmic reticulum-localized ECM1b suppresses tumor growth and regulates MYC and MTORC1 through modulating MTORC2 activation in esophageal squamous cell carcinoma.
    Yu VZ; Ko JMY; Ning L; Dai W; Law S; Lung ML
    Cancer Lett; 2019 Oct; 461():56-64. PubMed ID: 31319137
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transcriptional inhibition by CDK7/9 inhibitor SNS-032 suppresses tumor growth and metastasis in esophageal squamous cell carcinoma.
    Zeng H; Yang H; Song Y; Fang D; Chen L; Zhao Z; Wang C; Xie S
    Cell Death Dis; 2021 Nov; 12(11):1048. PubMed ID: 34741018
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A GRN Autocrine-Dependent FAM135B/AKT/mTOR Feedforward Loop Promotes Esophageal Squamous Cell Carcinoma Progression.
    Dong D; Zhang W; Xiao W; Wu Q; Cao Y; Gao X; Huang L; Wang Y; Chen J; Wang W; Zhan Q
    Cancer Res; 2021 Feb; 81(4):910-922. PubMed ID: 33323378
    [TBL] [Abstract][Full Text] [Related]  

  • 50. miR-516b functions as a tumor suppressor by directly modulating CCNG1 expression in esophageal squamous cell carcinoma.
    Zhao Y; Wang Y; Xing G
    Biomed Pharmacother; 2018 Oct; 106():1650-1660. PubMed ID: 30119241
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The PSMD14 inhibitor Thiolutin as a novel therapeutic approach for esophageal squamous cell carcinoma through facilitating SNAIL degradation.
    Jing C; Li X; Zhou M; Zhang S; Lai Q; Liu D; Ye B; Li L; Wu Y; Li H; Yue K; Chen P; Yao X; Wu Y; Duan Y; Wang X
    Theranostics; 2021; 11(12):5847-5862. PubMed ID: 33897885
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genome-wide copy number variation analysis identified ANO1 as a novel oncogene and prognostic biomarker in esophageal squamous cell cancer.
    Yu Y; Cao J; Wu W; Zhu Q; Tang Y; Zhu C; Dai J; Li Z; Wang J; Xue L; Zhen F; Liu J; Huang C; Zhao F; Zhou Y; Wen W; Pan X; Wei H; Zhu Y; He Y; Que J; Wang W; Luo J; Xu J; Chen L
    Carcinogenesis; 2019 Oct; 40(10):1198-1208. PubMed ID: 31050728
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Far upstream element-binding protein 1 (FUBP1) is a potential c-Myc regulator in esophageal squamous cell carcinoma (ESCC) and its expression promotes ESCC progression.
    Yang L; Zhu JY; Zhang JG; Bao BJ; Guan CQ; Yang XJ; Liu YH; Huang YJ; Ni RZ; Ji LL
    Tumour Biol; 2016 Mar; 37(3):4115-26. PubMed ID: 26490982
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sequestosome 1 protects esophageal squamous carcinoma cells from apoptosis via stabilizing SKP2 under serum starvation condition.
    Shi C; Pan BQ; Shi F; Xie ZH; Jiang YY; Shang L; Zhang Y; Xu X; Cai Y; Hao JJ; Wang MR
    Oncogene; 2018 Jun; 37(24):3260-3274. PubMed ID: 29551772
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vascular endothelial growth factor-C upregulates cortactin and promotes metastasis of esophageal squamous cell carcinoma.
    Su CM; Su YH; Chiu CF; Chang YW; Hong CC; Yu YH; Ho YS; Wu CH; Yen CS; Su JL
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S767-75. PubMed ID: 25212831
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CircPDE5A-encoded novel regulator of the PI3K/AKT pathway inhibits esophageal squamous cell carcinoma progression by promoting USP14-mediated de-ubiquitination of PIK3IP1.
    Lei K; Liang R; Liang J; Lu N; Huang J; Xu K; Tan B; Wang K; Liang Y; Wang W; Lin H; Wang M
    J Exp Clin Cancer Res; 2024 Apr; 43(1):124. PubMed ID: 38658954
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rack1 mediates tyrosine phosphorylation of Anxa2 by Src and promotes invasion and metastasis in drug-resistant breast cancer cells.
    Fan Y; Si W; Ji W; Wang Z; Gao Z; Tian R; Song W; Zhang H; Niu R; Zhang F
    Breast Cancer Res; 2019 May; 21(1):66. PubMed ID: 31113450
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interleukin-33-nuclear factor-κB-CCL2 signaling pathway promotes progression of esophageal squamous cell carcinoma by directing regulatory T cells.
    Yue Y; Lian J; Wang T; Luo C; Yuan Y; Qin G; Zhang B; Zhang Y
    Cancer Sci; 2020 Mar; 111(3):795-806. PubMed ID: 31883400
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting leucine-rich PPR motif-containing protein/LRPPRC by 5,7,4'-trimethoxyflavone suppresses esophageal squamous cell carcinoma progression.
    Liu H; Zhou Y; Fredimoses M; Niu P; Ge Y; Wu R; Liu T; Li P; Shi Y; Shi Y; Liu K; Dong Z
    Int J Biol Macromol; 2024 Jun; 269(Pt 1):131966. PubMed ID: 38697422
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The regulation of acetylation and stability of HMGA2 via the HBXIP-activated Akt-PCAF pathway in promotion of esophageal squamous cell carcinoma growth.
    Wu Y; Wang X; Xu F; Zhang L; Wang T; Fu X; Jin T; Zhang W; Ye L
    Nucleic Acids Res; 2020 May; 48(9):4858-4876. PubMed ID: 32313942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.